Nah, with the importance of this round, TACTI003 will never be released in such a small conference, has to be tier 1 conferences, AACR (IMM is never a big fan of this), ASCO (onn the website already confirmed the attendence), EMSO and SITC (highly likely to release second round of data with the 2nd half two T1 meetings)
An obsevation re Eftiligomab alfa, page-21
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.5¢ | 32.8¢ | $839.2K | 2.469M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 125437 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 85415 | 6 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |